Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting cancer drug resistance utilizing organoid technology
Changpeng Chai, Pengfei Ji, Hao Xu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114098-114098
Open Access | Times Cited: 18

Showing 18 citing articles:

Platelet membrane fusion liposome loaded with type I AIE photosensitizer to induce chemoresistance cancer pyroptosis and immunogenic cell death for enhancing cancer immunotherapy
Hao Chen, Xi Luo, Qinghua Huang, et al.
Chemical Engineering Journal (2023) Vol. 476, pp. 146276-146276
Closed Access | Times Cited: 26
Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research
Mohammad Waseem, Bi‐Dar Wang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1093-1093
Open Access | Times Cited: 8
Breast cancer organoids derived from patients: A platform for tailored drug screening
Yen‐Dun Tony Tzeng, Jui‐Hu Hsiao, Ling‐Ming Tseng, et al.
Biochemical Pharmacology (2023) Vol. 217, pp. 115803-115803
Open Access | Times Cited: 14
Development of glioblastoma organoids and their applications in personalized therapy
Can Xu, Xiaoye Yuan, Pengyu Hou, et al.
Cancer Biology and Medicine (2023) Vol. 20, Iss. 5, pp. 353-368
Open Access | Times Cited: 12
Geniposide Inhibits Non-Small Cell Lung Cancer by Regulating Proliferation, Apoptosis, Invasion, Migration, Epithelial-Mesenchymal Transition, and Cancer Stem-Like Cell Property Via Wnt/β-Catenin Pathway
Haifa He, Li Yin, Yuan Wang, et al.
Biochemical Genetics (2025)
Closed Access
Unlocking the potential of organoids in cancer treatment and translational research: An application of cytologic techniques
Mohamed Abd El-Salam, Maria J. Troulis, Chong-xian Pan, et al.
Cancer Cytopathology (2023) Vol. 132, Iss. 2, pp. 96-102
Closed Access | Times Cited: 4
Targeted Cancer Therapy‐on‐A‐Chip
Heba Abed, R. Radha, Shabana Anjum, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 29
Open Access | Times Cited: 1
Evolving Landscape of Detection and Targeting miRNA/Epigenetics for Therapeutic Strategies in Ovarian Cancer
Arpan Dey Bhowmik, Pallab Shaw, Mohan Shankar Gopinatha Pillai, et al.
Cancer Letters (2024) Vol. 611, pp. 217357-217357
Closed Access | Times Cited: 1
Stemness regulation in prostate cancer: prostate cancer stem cells and targeted therapy
Hao Liang, Bin Zhou, Pei-Xin Li, et al.
Annals of Medicine (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 1
Trace elements and metal nanoparticles: mechanistic approaches to mitigating chemotherapy-induced toxicity—a review of literature evidence
Ademola C. Famurewa, Mina Y. George, Cletus Anes Ukwubile, et al.
BioMetals (2024) Vol. 37, Iss. 6, pp. 1325-1378
Closed Access | Times Cited: 1
siRNA-based therapy for overcoming drug resistance in human solid tumours; molecular and immunological approaches
Harikumar Pallathadka, Majid S. Jabir, Khetam H. Rasool, et al.
Human Immunology (2024) Vol. 86, Iss. 1, pp. 111221-111221
Closed Access | Times Cited: 1
Research progress on the regulatory mechanisms of FOXC1 expression in cancers and its role in drug resistance
Yihui Yang, Li Wan, Hong Yang, et al.
Gene (2023) Vol. 897, pp. 148079-148079
Closed Access | Times Cited: 2
HGFK1 Enhances the Anti-Tumor Effects of Angiogenesis Inhibitors via Inhibition of CD90+ CSCs in Hepatocellular Carcinoma
Tian‐Yue Li, Ling Liu, Li Li, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 645-645
Open Access
[Application and Research Progress of Lung Cancer Organoid in Precision Medicine 
for Lung Cancer].
Zhicheng Huang, Bowen Li, Yadong Wang, et al.
PubMed (2024) Vol. 27, Iss. 4, pp. 276-282
Closed Access
KHDRBS3 facilitates self-renewal and temozolomide resistance of glioblastoma cell lines
Kanokkuan Somrit, Sucheewin Krobthong, Yodying Yingchutrakul, et al.
Life Sciences (2024), pp. 123132-123132
Closed Access
Comprehensive review of signaling pathways and therapeutic targets in gastrointestinal cancers
Pengfei Ji, Tingting Chen, Chao Li, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 206, pp. 104586-104586
Open Access
Chromatin Remodeling-Related PRDM1 Increases Stomach Cancer Proliferation and Is Counteracted by Bromodomain Inhibitor
Yu‐Hsuan Hung, Hui‐Ching Wang, Mei‐Ren Pan, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 3, pp. 224-224
Open Access
Personalized Medicine for Meningiomas: Drug Screening on Tumor Organoids Exposes Therapeutic Vulnerabilities to HDAC1/2i Panobinostat
Gerhard Jungwirth, Junguo Cao, Catharina Lotsch, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top